Assessment of body composition in oncologic patients: Experimental survey on the role of bioimpedentiometric analysis

1Planas M, Alvarez-Hernandez J, Leon-Sanz M, Celaya-Perez S., Araujo K, Garcia De Lorenzo A. Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® study. Support Care Cancer. 2016; 24:429–435. https://doi.org/10.1007/s00520-015-2813-7PlanasMAlvarez-HernandezJLeon-SanzMCelaya-PerezS.AraujoKGarcia De LorenzoA.Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES® studySupport Care Cancer201624429435https://doi.org/10.1007/s00520-015-2813-710.1007/s00520-015-2813-7Search in Google Scholar

2Arends J., Baracos V., Bertz H, F. Bozzetti, Calder P.C., Deutz N.E.P, Erickson N., Laviano A., Lisanti M.P., Lobo D.N., Mcmillan D.C., Muscaritoli M., Ockenga J., Pirlich M., Strasser F., De Van Der Schueren M. ESPEN expert group recommendations for action against cancer-related malnutrition, Clinical Nutrition, 2017; 36 (5): 1187–1196. https://doi.org/10.1016/j.clnu.2017.06.017ArendsJ.BaracosV.BertzHBozzettiF.CalderP.C.DeutzN.E.PEricksonN.LavianoA.LisantiM.P.LoboD.N.McmillanD.C.MuscaritoliM.OckengaJ.PirlichM.StrasserF.De Van Der SchuerenM.ESPEN expert group recommendations for action against cancer-related malnutritionClinical Nutrition201736511871196https://doi.org/10.1016/j.clnu.2017.06.01710.1016/j.clnu.2017.06.017Search in Google Scholar

3Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83: 1345–1350. https://doi.org/10.1093/ajcn/83.6.1345FearonK.C.VossA.C.HusteadD.S.Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosisAm J Clin Nutr20068313451350https://doi.org/10.1093/ajcn/83.6.134510.1093/ajcn/83.6.1345Search in Google Scholar

4Cederholm T., Barazzoni R., Austin P., Ballmer P., Biolo G., Bischoff S.C., Compher C., Correia I., Higashiguchi T., Holst M., Jensen G.L., Malone A., Muscaritoli M. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017; 36:49–64. https://doi.org/10.1016/j.clnu.2016.09.004CederholmT.BarazzoniR.AustinP.BallmerP.BioloG.BischoffS.C.CompherC.CorreiaI.HigashiguchiT.HolstM.JensenG.L.MaloneA.MuscaritoliM.ESPEN guidelines on definitions and terminology of clinical nutritionClin Nutr2017364964https://doi.org/10.1016/j.clnu.2016.09.00410.1016/j.clnu.2016.09.004Search in Google Scholar

5Lochs H., Allison S.P., Meier R., Pirlich M., Kondrup J., Schneider S., Van Den Berghe G., Pichard C. Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr. 2006;25(2): 180–186. https://doi.org/10.1016/j.clnu.2006.02.007LochsH.AllisonS.P.MeierR.PirlichM.KondrupJ.SchneiderS.Van Den BergheG.PichardC.Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topicsClin Nutr2006252180186https://doi.org/10.1016/j.clnu.2006.02.00710.1016/j.clnu.2006.02.007Search in Google Scholar

6Blauwhoff-Buskermolen S., Ruijgrok C., Ostelo R., De Vet H., Verheul H., De Van Der Schueren M. The assessment of anorexia in patients with cancer: Cut-off values for the FAACTA/CS and the VAS for appetite. Support Care Cancer 2016;24:661–666. https://doi.org/10.1007/s00520-015-2826-2Blauwhoff-BuskermolenS.RuijgrokC.OsteloR.De VetH.VerheulH.De Van Der SchuerenM.The assessment of anorexia in patients with cancer: Cut-off values for the FAACTA/CS and the VAS for appetiteSupport Care Cancer201624661666https://doi.org/10.1007/s00520-015-2826-210.1007/s00520-015-2826-2Search in Google Scholar

7Hebuterne X., Lemarie E., Michallet M., De Montreuil C.B., Schneider S.M., Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38:196–204. https://doi.org/10.1177/0148607113502674HebuterneX.LemarieE.MichalletM.De MontreuilC.B.SchneiderS.M.GoldwasserF.Prevalence of malnutrition and current use of nutrition support in patients with cancerJPEN J Parenter Enteral Nutr201438196204https://doi.org/10.1177/014860711350267410.1177/0148607113502674Search in Google Scholar

8Pressoir M., Desne S., Berchery D., Rossignol G., Poiree B., Meslier M., Traversier S., Vittot M., Simon M., Gekiere J.P., Meuric J., Serot F., Falewee M.N. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–971. https://doi.org/10.1038/sj.bjc.6605578PressoirM.DesneS.BercheryD.RossignolG.PoireeB.MeslierM.TraversierS.VittotM.SimonM.GekiereJ.P.MeuricJ.SerotF.FaleweeM.N.Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer CentresBr J Cancer2010102966971https://doi.org/10.1038/sj.bjc.660557810.1038/sj.bjc.6605578Search in Google Scholar

9Hamaker ME, van Huis-Tanja LH, Rostoft S. Optimizing the geriatrician’s contribution to cancer care for older patients. J Geriatr Oncol. 2019 (in press). https://doi.org/10.1016/j.jgo.2019.06.018HamakerMEvan Huis-TanjaLHRostoftS.Optimizing the geriatrician’s contribution to cancer care for older patientsJ Geriatr Oncol2019(in press). https://doi.org/10.1016/j.jgo.2019.06.01810.1016/j.jgo.2019.06.018Search in Google Scholar

10Martin L., Senesse P., Gioulbasanis I. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol 2015; 33: 90–9.MartinL.SenesseP.GioulbasanisI.Diagnostic criteria for the classification of cancer-associated weight lossJ Clin Oncol20153390910.1200/JCO.2014.56.1894Search in Google Scholar

11Del Fabbro E. Current and future care of patients with the cancer anorexia-cachexia syndrome. Am Soc Clin Oncol Educ Book 2015; e229–37. https://doi.org/10.14694/edbook_am.2015.35.e229Del FabbroE.Current and future care of patients with the cancer anorexia-cachexia syndromeAm Soc Clin Oncol Educ Book2015e22937https://doi.org/10.14694/edbook_am.2015.35.e22910.14694/EdBook_AM.2015.35.e229Search in Google Scholar

12Gonzalez M.C., Barbosa-Silva T.G., Bielemann R.M., Gallagher D., Heymsfield S.B.: Phase angle and its determinants in healthy subjects: influence of body composition Am J Clin Nutr. 2016;103(3):712–6. https://doi.org/10.3945/ajcn.115.116772GonzalezM.C.Barbosa-SilvaT.G.BielemannR.M.GallagherD.HeymsfieldS.B.Phase angle and its determinants in healthy subjects: influence of body compositionAm J Clin Nutr201610337126https://doi.org/10.3945/ajcn.115.11677210.3945/ajcn.115.116772Search in Google Scholar

13Bosy-Westphal A., Danielzik S., Dörhöfer R.P., Later W., Wiese S., Müller M.J. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN 2006;30:309–316. https://doi.org/10.1177/0148607106030004309Bosy-WestphalA.DanielzikS.DörhöferR.P.LaterW.WieseS.MüllerM.J.Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass indexJPEN200630309316https://doi.org/10.1177/014860710603000430910.1177/0148607106030004309Search in Google Scholar

14Lee S.Y., Lee Y.., Yang J.H., Kim C.M., Choi W.S. The Association between Phase Angle of Bioelectrical Impedance Analysis and Survival Time in Advanced Cancer Patients: Preliminary Study. Korean J Fam Med 2014;35:251–256. https://doi.org/10.4082/kjfm.2014.35.5.251LeeS.Y.LeeY.YangJ.H.KimC.M.ChoiW.S.The Association between Phase Angle of Bioelectrical Impedance Analysis and Survival Time in Advanced Cancer Patients: Preliminary StudyKorean J Fam Med201435251256https://doi.org/10.4082/kjfm.2014.35.5.25110.4082/kjfm.2014.35.5.251Search in Google Scholar

15Gupta D., Lammersfeld C.A., Vashi P.G., King J., Dahlk S.L., Grutsch J.F. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008;8:249. https://doi.org/10.1186/1471-2407-8-249GuptaD.LammersfeldC.A.VashiP.G.KingJ.DahlkS.L.GrutschJ.F.Bioelectrical impedance phase angle as a prognostic indicator in breast cancerBMC Cancer20088249https://doi.org/10.1186/1471-2407-8-24910.1186/1471-2407-8-249Search in Google Scholar

16Muscaritoli M. Perspectives of health care professionals on cancer cachexia: results from three global surveys. Ann Oncol. 2016;27(12):2230–2236. https://doi.org/10.1093/annonc/mdw420MuscaritoliM.Perspectives of health care professionals on cancer cachexia: results from three global surveysAnn Oncol2016271222302236https://doi.org/10.1093/annonc/mdw42010.1093/annonc/mdw420Search in Google Scholar

17Nishioka N., Uchino J., Hirai S. Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer. J Clin Med. 2019;8(4):450. https://doi.org/10.3390/jcm8040450NishiokaN.UchinoJ.HiraiS.Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung CancerJ Clin Med201984450https://doi.org/10.3390/jcm804045010.3390/jcm8040450Search in Google Scholar

18Boshier P.R., Henegan R., Markar S.R., Baracos V.E., Low D.E. Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Diseases of the Esophagus. 2018;31(8):1040–47. https://doi.org/10.1093/dote/doy089.ps02.248BoshierP.R.HeneganR.MarkarS.R.BaracosV.E.LowD.E.Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysisDiseases of the Esophagus2018318104047https://doi.org/10.1093/dote/doy089.ps02.24810.1093/dote/doy089.PS02.248Search in Google Scholar

19Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr. 2003;22(3):235–9. https://doi.org/10.1016/s0261-5614(02)00215-7CorreiaMIWaitzbergDL.The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysisClin Nutr20032232359https://doi.org/10.1016/s0261-5614(02)00215-710.1016/S0261-5614(02)00215-7Search in Google Scholar

20Koch C., Reitz C., Schrekenbach T. Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma. Plos One 2019;14(10):e0223613. https://doi.org/10.1371/journal.pone.0223613KochC.ReitzC.SchrekenbachT.Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinomaPlos One20191410e0223613https://doi.org/10.1371/journal.pone.022361310.1371/journal.pone.0223613Search in Google Scholar